As a senior consultant at Lumanity I tackle a breadth of projects in oncology and other therapeutic areas across the product lifecycle, which include early-stage opportunity assessments, indication prioritizations, competitive intelligence, and later-stage brand planning.

Prior to Lumanity, I completed my PhD at Weill Cornell Medicine & Memorial Sloan Kettering Cancer Center. I developed immune cell-targeted PET imaging agents with the goal of non-invasively detecting immunotherapeutic responses in brain tumor patients. At the time, I was focused on preclinical development so I had limited insight into the clinical development of these tracers and the potential impact non-invasive imaging can have on a patient’s care. To better understand drug development beyond the bench and more tangibly contribute to patient care, I sought opportunities to engage with the clinical development and life cycle management of transformative therapies at life sciences strategy consulting firms.

I participated in several experiential programs to understand how different consultancies tackle complex business issues in the biopharma space, which included Lumanity’s Propel program. Throughout Propel, I learned about our approach to consulting through panel presentations and participated in a simulated case led by Lumanity consultants. During the program I experienced a supportive environment and learned about professional growth opportunities. Beyond reinforcing my desire to pursue life science consulting, Propel made it clear that Lumanity would be an excellent place to start my career due to the culture and blend of scientific rigor and commercial expertise among the multidisciplinary team.

Since joining I’ve progressed from entry-level senior associate to mid-level senior consultant. On case teams every member plays a critical role regardless of their position level. As a senior associate, I performed primary and secondary research-based analyses and as I progressed to the senior consultant, I began framing client problems, planning workstreams for others, and eventually taking on the case team lead role.

Work as a strategic consultant is exciting and dynamic, combining innovative science and strategic business decisions with the aim to improve outcomes for patients. I am grateful to leverage my PhD training to tackle complex problems and collaborate with colleagues from a variety of professional backgrounds in identifying innovative and transformative solutions for our clients.